{"component": "definition", "props": {"groups": [{"size": 6, "snippet_links": [{"key": "limited-liability-company", "type": "definition", "offset": [46, 71]}], "samples": [{"hash": "5ff7WwIanrh", "uri": "https://www.sec.gov/Archives/edgar/data/1325702/000095012310036061/f54652a1exv2w1.htm", "label": "Magnachip Semiconductor LLC", "score": 5.2984257358, "published": false}, {"hash": "5LNGwZnEyPh", "uri": "https://casedocs.omniagentsolutions.com/cmsvol/CMSDocs/pub_45403/120409_Committee%20Disclosure.pdf", "label": "casedocs.omniagentsolutions.com", "score": 5.0, "published": false}, {"hash": "KV9EBhaYfs", "uri": "http://bankrupt.com/misc/MagnaCh_CreditorsAmendedDS.pdf", "label": "bankrupt.com", "score": 5.0, "published": false}], "snippet": "means MagnaChip Semiconductor, Ltd., a Korean limited liability company.", "hash": "dfcb568855a81cbf9368202180d96aba", "id": 1}, {"size": 5, "snippet_links": [], "samples": [{"hash": "bBynL3DZnJn", "uri": "/contracts/bBynL3DZnJn#msk", "label": "Commercialization Agreement (Atara Biotherapeutics, Inc.)", "score": 35.2368240931, "published": true}, {"hash": "1syOkAEaZ9f", "uri": "/contracts/1syOkAEaZ9f#msk", "label": "Purchase and Sale Agreement (Atara Biotherapeutics, Inc.)", "score": 34.1033538672, "published": true}, {"hash": "eNzhHnpuSMs", "uri": "/contracts/eNzhHnpuSMs#msk", "label": "Commercialization Agreement (Atara Biotherapeutics, Inc.)", "score": 33.1587953457, "published": true}], "snippet": "means the Memorial Sloan Kettering Cancer Center.", "hash": "79a59b32740faaa05a76a16839cdfe8d", "id": 2}, {"size": 3, "snippet_links": [{"key": "limited-company", "type": "clause", "offset": [39, 54]}, {"key": "organized-and-existing", "type": "clause", "offset": [71, 93]}, {"key": "the-laws", "type": "definition", "offset": [100, 108]}, {"key": "republic-of-korea", "type": "clause", "offset": [116, 133]}, {"key": "subsidiary-of-the-company", "type": "definition", "offset": [146, 171]}], "samples": [{"hash": "fmXhjeE68yo", "uri": "/contracts/fmXhjeE68yo#msk", "label": "Merger Agreement (MAGNACHIP SEMICONDUCTOR Corp)", "score": 32.2388774812, "published": true}, {"hash": "1bCFt9CFeeB", "uri": "https://investors.magnachip.com/static-files/d4def8f6-d823-4915-97a1-f66a106b7077", "label": "investors.magnachip.com", "score": 10.6194387406, "published": false}, {"hash": "31crctWRxAa", "uri": "https://investors.magnachip.com/index.php/static-files/943a039c-ece5-42d5-af7d-b7425294b4e6", "label": "investors.magnachip.com", "score": 10.6194387406, "published": false}], "snippet": "means Magnachip Semiconductor, Ltd., a limited company (\u201cyuhan hoesa\u201d) organized and existing under the Laws of the Republic of Korea, which is a Subsidiary of the Company.", "hash": "346694364206dffb6273b16826dc159d", "id": 3}, {"size": 2, "snippet_links": [{"key": "participating-employers", "type": "definition", "offset": [69, 92]}, {"key": "related-to", "type": "clause", "offset": [102, 112]}, {"key": "cancer-research", "type": "definition", "offset": [216, 231]}, {"key": "graduate-school", "type": "definition", "offset": [263, 278]}], "samples": [{"hash": "csj9GNrjXcq", "uri": "https://www.tiaa.org/content/dam/tiaa/microsites/pdfs/plan-document/spd/SPD_102488_102489.pdf", "label": "www.tiaa.org", "score": 8.7180013689, "published": false}, {"hash": "lqaALrxIvbj", "uri": "https://www.tiaa.org/public/pdf/mskcc_SPD_102489_102489.pdf", "label": "www.tiaa.org", "score": 8.279945243, "published": false}], "snippet": "means the Memorial Sloan Kettering Cancer Center, as well as certain participating employers that are related to MSK, including the Memorial Hospital for Cancer and Allied Diseases, the Sloan Kettering Institute for Cancer Research, and the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences.", "hash": "037b49d8cbccc734882dd8649637dda0", "id": 4}, {"size": 2, "snippet_links": [{"key": "cancer-research", "type": "definition", "offset": [130, 145]}], "samples": [{"hash": "3HcNUdo4HVb", "uri": "http://140.163.1.151/teaser/board-managers-conflict-interest-policy.pdf", "label": "140.163.1.151", "score": 10.7275838467, "published": false}, {"hash": "k8J83OoZLcv", "uri": "https://www.mskcc.org/teaser/board-managers-conflict-interest-policy.pdf", "label": "www.mskcc.org", "score": 10.2594113621, "published": false}], "snippet": "means Memorial Sloan Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, and Sloan Kettering Institute for Cancer Research.", "hash": "0e1de91c009eba5aa4b8ddc12e044b78", "id": 5}, {"size": 2, "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [36, 48]}], "samples": [{"hash": "7rccT6DGTbp", "uri": "/contracts/7rccT6DGTbp#msk", "label": "Joint Venture Agreement (Sequana Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "27xWnQU04L7", "uri": "/contracts/27xWnQU04L7#msk", "label": "Joint Venture Agreement (Sequana Therapeutics Inc)", "score": 18.0, "published": true}], "snippet": "shall have the meaning set forth in the preamble hereto.", "hash": "28960b95fcba0d7e9fb0f901aaa2499d", "id": 6}, {"size": 2, "snippet_links": [{"key": "successor-in-interest", "type": "clause", "offset": [70, 91]}, {"key": "license-agreement", "type": "definition", "offset": [132, 149]}], "samples": [{"hash": "iKefaae3hZN", "uri": "/contracts/iKefaae3hZN#msk", "label": "Exclusive License Agreement (SELLAS Life Sciences Group, Inc.)", "score": 32.0746064339, "published": true}, {"hash": "j6jrBhhYaHT", "uri": "http://pdf.secdatabase.com/1047/0001104659-21-008294.pdf", "label": "pdf.secdatabase.com", "score": 10.8754277892, "published": false}], "snippet": "means the Memorial Sloan Kettering Cancer Center, and any assignee or successor in interest to such entity\u2019s interest under the MSK License Agreement.", "hash": "6e90a7c23566320e66a770155591470f", "id": 7}, {"size": 2, "snippet_links": [], "samples": [{"hash": "arvjdb2CgXw", "uri": "/contracts/arvjdb2CgXw#msk", "label": "Merger Agreement (KINS Technology Group, Inc.)", "score": 33.733744011, "published": true}, {"hash": "1s8NSBaRedM", "uri": "/contracts/1s8NSBaRedM#msk", "label": "Merger Agreement (Inpixon)", "score": 33.733744011, "published": true}], "snippet": "has the meaning specified in Section 11.18(b).", "hash": "567ac00c02f0d3ea35a379e1d2023f13", "id": 8}, {"size": 2, "snippet_links": [{"key": "place-of-business", "type": "clause", "offset": [52, 69]}], "samples": [{"hash": "jxiOo00x7CL", "uri": "/contracts/jxiOo00x7CL#msk", "label": "Research and Development and License Agreement (Atara Biotherapeutics, Inc.)", "score": 32.3374401095, "published": true}, {"hash": "4GESAH7jTph", "uri": "/contracts/4GESAH7jTph#msk", "label": "Research and Development and License Agreement (Atara Biotherapeutics, Inc.)", "score": 32.1622176591, "published": true}], "snippet": "means Memorial Sloan Kettering Cancer Center with a place of business located at \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587 \u2587\u2587\u2587\u2587, \u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587.\u2587.\u2587.", "hash": "a2dd7bbc4c03f8ed00cbcd2a992518e3", "id": 9}, {"size": 2, "snippet_links": [], "samples": [{"hash": "35QTjn30Vaf", "uri": "/contracts/35QTjn30Vaf#msk", "label": "Securities Purchase Agreement (Snail, Inc.)", "score": 34.659137577, "published": true}], "snippet": "means M\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 & K\u2587\u2587\u2587\u2587 LLP with offices located at 4\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587., \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587 \u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587.", "hash": "6d8917d4a2d149aeb5c23baedf203307", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMbXNrIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 35, "title": "MSK", "snippet": "means MagnaChip Semiconductor, Ltd., a Korean limited liability company.", "id": "msk", "examples": ["The Musculoskeletal Services Framework (July 2006) the Arthritis and Musculoskeletal Alliance (ARMA), the DH <strong>MSK</strong> Framework 2006 and the Arthritis Research Campaign (ARC) all support the role of therapists in the management of musculoskeletal conditions.", "<strong>MSK</strong> neither represents that a license shall not be required nor that, if required, it shall be issued.", "Under <strong>MSK</strong> policy, inventions and discoveries which result from research or other activities carried out at <strong>MSK</strong> or with the substantial aid of its facilities or funds administered by it, are disclosed to <strong>MSK</strong> and are the property of <strong>MSK</strong>.", "<strong>MSK</strong> at all times reserves the right to select and retain counsel of its own at its own expense to defend <strong>MSK</strong>\u2019s interests.", "LICENSEE shall keep <strong>MSK</strong> timely informed of any activities by LICENSEE in regard hereto.", "<strong>MSK</strong> shall join in any such action, at LICENSEE\u2019s request and expense.", "Sponsor shall require that its personnel respect the confidential nature of all medical information relating to <strong>MSK</strong> patients.", "<strong>MSK</strong> MAKES NO WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, AS TO ANY MATTER INCLUDING, BUT NOT LIMITED TO, WARRANTY OF FITNESS FOR PARTICULAR PURPOSE, MERCHANTABILITY, EXCLUSIVITY OR TO FREEDOM FROM INTELLECTUAL PROPERTY INFRINGEMENT.", "Sponsor shall hold such disclosure on a confidential basis and shall not disclose the information to any third party, or use the information, without the prior written consent of <strong>MSK</strong>.", "If Sponsor elects to exercise the option, Sponsor will provide <strong>MSK</strong> written notice of said election (the \u201cNotice\u201d)."], "related": [["merck", "Merck", "Merck"], ["bms", "BMS", "BMS"], ["lilly", "Lilly", "Lilly"], ["novartis", "Novartis", "Novartis"], ["gsk", "GSK", "GSK"]], "related_snippets": [], "updated": "2025-07-06T21:58:30+00:00"}, "json": true, "cursor": ""}}